English press releases

Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain

– Rolling submission for suzetrigine moderate-to-severe acute pain NDA granted by FDA; first module submitted and on track to complete filing this quarter – –...

Merck Inspires Students to Explore STEM Careers with 2024 Curiosity Cube Tour

Curiosity Cube mobile science lab plans to reach 45,000 students in 14 countries Lessons educate students on sustainability topics, such as renewable energy and recycled...

Visa Reimagines Payment Acceptance for the ‘Click-and-Mortar’ Era

Visa Acceptance Solutions helps accelerate growth for merchants with new digital enablement offerings SAN FRANCISCO–(BUSINESS WIRE)– With a new fast-growing segment of ‘Click-and-Mortar™, shoppers who...

Samsung Develops Industry’s Fastest 10.7Gbps LPDDR5X DRAM, Optimized for AI Applications

Industry-leading features come with 25% higher performance, 30% more capacity and 25% higher power efficiency The new LPDDR5X is the optimal solution for future on-device...

Clearstream to invest in Digital Vault Services

Partnership underlines joint commitment to further progress digitisation of the financial markets Investment dedicated to accelerate DVS’s offering as a market infrastructure solution for the...

IFF to Release First Quarter 2024 Results on May 6, 2024

NEW YORK–(BUSINESS WIRE)– IFF (NYSE:IFF) today announced that it will release its first quarter 2024 earnings results following the market close on Monday, May 6,...

Merck Launches First All-in-One Genetic Stability Assay to Accelerate Biosafety Testing

Proprietary Aptegra™ platform reduces five assays to one Results in 66% faster testing time and significantly lower cost for clients compared to traditional methods Only...

Arthur D. Little Publishes Human After All – Latest Edition of PRISM Magazine

LONDON–(BUSINESS WIRE)– Arthur D. Little (ADL) has published Human After All – the latest edition of its strategy and innovation magazine PRISM. As we enter...

MRM Health Reports Safety and Positive Efficacy Data in Pouchitis in Phase 2a Clinical Study with MH002

Met primary endpoint of safety: MH002 was safe and well tolerated with no evidence of adverse reactions when administered for 8 weeks. Clinical remission rate...

FPT Unveils Strategic Directions, “All In” on AI, Automotive and Semiconductor

HANOI, Vietnam–(BUSINESS WIRE)– FPT Corporation (FPT) announced its strategic directions for the 2024-2026 period at the 2024 Annual General Meeting, with five focused areas defined...

Nike Kicks Off Multi-Year Innovation Cycle

New products fueled by insights from the world’s leading athletes, brought to life by computational design and advanced manufacturing PARIS–(BUSINESS WIRE)– Today, NIKE, Inc. (NYSE:...

Giesecke+Devrient Sets New Highs and Generates Revenues of Three Billion Euros for the First Time

MUNICH–(BUSINESS WIRE)– Giesecke+Devrient (G+D) achieved the strongest growth in its history in fiscal year 2023, setting new records for sales, sales growth, and earnings. The...

APRIL Group Launches Its Spring 2027 Strategic Plan With the Ambition of Becoming a European Leader With a Global Stature in the Mass Market

PARIS–(BUSINESS WIRE)– Building on the success of its first transformation plan, APRIL is embarking on a new phase in its development with the ambition of...

Donald Quintin Named Chief Executive Officer and Global President of Lone Star

DALLAS & NEW YORK & LONDON & TOKYO–(BUSINESS WIRE)– Lone Star has announced to its Limited Partners and employees that Donald Quintin has been appointed...

Vertex Enters Into Agreement to Acquire Alpine Immune Sciences

– Alpine is a clinical stage biotechnology company focused on discovering and developing innovative, protein-based immunotherapies – – Alpine’s lead product, povetacicept, demonstrated best-in-class potential...